Get Cash Back and $0 Commissions
+ The Power of TradeStation
Business Wire 26-Feb-2025 2:05 AM
Delivers annual sales of $6,841 million, adjusted EBITDA of $1,469 million and earnings per share of $0.38
Specialties-driven EBITDA reaches 70% of total adjusted EBITDA for the year and 73% in the fourth quarter
ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the fourth quarter and full year ended December 31, 2024. Consolidated annual sales were $6,841 million versus $7,536 million in 2023. Net income was $407 million versus $647 million, while adjusted net income was $484 million versus $715 million in 2023. Annual adjusted EBITDA was $1,469 million versus $1,754 million in 2023. Diluted earnings per share for 2024 were $0.32, while adjusted diluted EPS was $0.38. Operating cash flow was $1,468 million in 2024, similar to adjusted EBITDA, while free cash flow was $758 million. For 2024, the Company distributed $242 million in dividends to its shareholders.
For the fourth quarter of 2024, consolidated sales were $1,601 million versus $1,690 million in the fourth quarter of 2023. Net income and adjusted net income for the fourth quarter of 2024 were $70 million and $104 million, respectively, versus $67 million and $123 million, respectively, for the fourth quarter of 2023. Adjusted EBITDA in the fourth quarter was $347 million versus $357 million in the fourth quarter of 2023. Fourth quarter diluted earnings per share were $0.06, with adjusted diluted EPS of $0.08, versus $0.05 and $0.10, respectively in the fourth quarter of 2023. Operating cash flow was $452 million in the fourth quarter of 2024, similar to the fourth quarter of 2023.
"ICL delivered 2024 adjusted EBITDA of $1,469 million, with our specialties-driven businesses contributing 70% of that amount, as we continued to focus on cash generation while increasing market share across Industrial Products, Phosphate Solutions and Growing Solutions. We remain committed to growing our leadership position for these three businesses," said Raviv Zoller, president and CEO of ICL. "During 2024, amidst persistent potash price declines and geopolitical challenges, we achieved strong profitability and cashflow, introduced dozens of innovative specialties products, developed new global partnerships, set production records at multiple sites, completed complementary bolt-on acquisitions, and continued to be vigilant in the execution of cost savings and efficiency efforts, all while continuing to drive significant value to our shareholders through dividends. As a result of these items, as well as prudent timing of potash deliveries, we are entering 2025 in a solid position and looking forward to improving market conditions in key end-markets."
For 2025, the Company expects the specialties-driven segments' EBITDA to be between $0.95 billion to $1.15 billion. For Potash, the Company expects 2025 sales volumes to be between 4.5 million metric tons and 4.7 million metric tons. (1a).
Financial Figures and non-GAAP Financial Measures
|
10-12/2024 |
10-12/2023 |
1-12/2024 |
1-12/2023 |
||||||||||||
|
$ millions |
% of Sales |
$ millions |
% of Sales |
$ millions |
% of Sales |
$ millions |
% of Sales |
||||||||
Sales |
1,601 |
|
- |
|
1,690 |
|
- |
|
6,841 |
|
- |
|
7,536 |
|
- |
|
Gross profit |
535 |
|
33 |
|
560 |
|
33 |
|
2,256 |
|
33 |
|
2,671 |
|
35 |
|
Operating income |
147 |
|
9 |
|
149 |
|
9 |
|
775 |
|
11 |
|
1,141 |
|
15 |
|
Adjusted operating income (1) |
190 |
|
12 |
|
211 |
|
12 |
|
873 |
|
13 |
|
1,218 |
|
16 |
|
Net income attributable to the Company's shareholders |
70 |
|
4 |
|
67 |
|
4 |
|
407 |
|
6 |
|
647 |
|
9 |
|
Adjusted net income attributable to the Company's shareholders (1) |
104 |
|
6 |
|
123 |
|
7 |
|
484 |
|
7 |
|
715 |
|
9 |
|
Diluted earnings per share (in dollars) |
0.06 |
|
- |
|
0.05 |
|
- |
|
0.32 |
|
- |
|
0.50 |
|
- |
|
Diluted adjusted earnings per share (in dollars) (2) |
0.08 |
|
- |
|
0.10 |
|
- |
|
0.38 |
|
- |
|
0.55 |
|
- |
|
Adjusted EBITDA (2)(3) |
347 |
|
22 |
|
357 |
|
21 |
|
1,469 |
|
21 |
|
1,754 |
|
23 |
|
Cash flows from operating activities (4) |
452 |
|
- |
|
452 |
|
- |
|
1,468 |
|
- |
|
1,710 |
|
- |
|
Purchases of property, plant and equipment and intangible assets (5) |
267 |
|
- |
|
255 |
|
- |
|
713 |
|
- |
|
780 |
|
- |
(1) |
See "Adjustments to Reported Operating and Net income (non-GAAP)" below. |
(2) |
See "Adjusted EBITDA and Diluted Adjusted Earnings Per Share for the periods of activity" below. |
(3) |
In 2024, the Company's adjusted EBITDA was positively impacted by an immaterial accounting reclassification. For further information, see below in our Potash segment results. |
(4) |
Commencing Q2 2024, management reclassified interest received as cash flows from investing activities and interest paid as cash flows from financing activities, instead of under cash provided by operating activities. |
(5) |
See "Condensed consolidated statements of cash flows (unaudited)" in the appendix below. |
Segment Information
Industrial Products
The Industrial Products segment produces bromine from a highly concentrated solution in the Dead Sea and bromine-based compounds at its facilities in Israel, the Netherlands and China. In addition, the segment produces several grades of salts, magnesium chloride, magnesia-based products, phosphorus-based products and functional fluids.
Results of operations and key indicators
|
10-12/2024 |
10-12/2023 |
1-12/2024 |
1-12/2023 |
||||
|
$ millions |
$ millions |
$ millions |
$ millions |
||||
Segment Sales |
280 |
|
299 |
|
1,239 |
|
1,227 |
|
Sales to external customers |
275 |
|
294 |
|
1,220 |
|
1,206 |
|
Sales to internal customers |
5 |
|
5 |
|
19 |
|
21 |
|
Segment Operating Income |
55 |
|
39 |
|
224 |
|
220 |
|
Depreciation and amortization |
15 |
|
17 |
|
57 |
|
57 |
|
Segment EBITDA |
70 |
|
56 |
|
281 |
|
277 |
|
Capital expenditures |
38 |
|
29 |
|
94 |
|
91 |
Significant highlights for the fourth quarter
Results analysis for the period October – December 2024
|
Sales |
Expenses |
Operating income |
||||||
|
$ millions |
||||||||
Q4 2023 figures |
299 |
|
(260 |
) |
39 |
|
|||
Quantity |
(13 |
) |
10 |
|
(3 |
) |
|||
Price |
(6 |
) |
- |
|
(6 |
) |
|||
Exchange rates |
- |
|
- |
|
- |
|
|||
Raw materials |
- |
|
6 |
|
6 |
|
|||
Energy |
- |
|
2 |
|
2 |
|
|||
Transportation |
- |
|
(4 |
) |
(4 |
) |
|||
Operating and other expenses |
- |
|
21 |
|
21 |
|
|||
Q4 2024 figures |
280 |
|
(225 |
) |
55 |
|
Potash
The Potash segment produces and sells mainly potash, salts, magnesium and electricity. Potash is produced in Israel using an evaporation process to extract potash from the Dead Sea at Sodom and in Spain using conventional mining from an underground mine. The segment also produces and sells pure magnesium, magnesium alloys and chlorine. In addition, the segment sells salt products produced at its potash site in Spain. The segment operates a power plant in Sodom, which supplies electricity and steam to ICL facilities in Israel with any surplus electricity sold to external customers.
Results of operations and key indicators
|
10-12/2024 |
10-12/2023 |
1-12/2024 |
1-12/2023 |
||||
|
$ millions |
$ millions |
$ millions |
$ millions |
||||
Segment Sales |
422 |
474 |
1,656 |
2,182 |
||||
Potash sales to external customers |
315 |
336 |
1,237 |
1,693 |
||||
Potash sales to internal customers |
30 |
49 |
95 |
129 |
||||
Other and eliminations (1) |
77 |
89 |
324 |
360 |
||||
Gross Profit |
162 |
231 |
650 |
1,171 |
||||
Segment Operating Income |
69 |
122 |
250 |
668 |
||||
Depreciation and amortization |
61 |
46 |
242 |
175 |
||||
Segment EBITDA (2) |
130 |
168 |
492 |
843 |
||||
Capital expenditures |
116 |
132 |
332 |
384 |
||||
Potash price - CIF ($ per tonne) |
285 |
345 |
299 |
393 |
(1) |
Primarily includes salt produced in Spain, metal magnesium-based products, chlorine and sales of surplus electricity produced by ICL's power plant at the Dead Sea in Israel. |
(2) |
Following a nonmaterial accounting reclassification of certain assets, the Potash segment's EBITDA for Q4 2024 increased by $16 million and for the full year of 2024 by $65 million. |
Significant highlights for the fourth quarter
Additional segment information
Global potash market - average prices and imports:
Average prices |
|
10-12/2024 |
10-12/2023 |
VS Q4 2023 |
7-9/2024 |
VS Q3 2024 |
||||||||
Granular potash – Brazil |
CFR spot ($ per tonne) |
288 |
|
336 |
(14.3 |
)% |
300 |
(4.0 |
)% |
|||||
Granular potash – Northwest Europe |
CIF spot/contract (€ per tonne) |
338 |
|
388 |
(12.9 |
)% |
340 |
(0.6 |
)% |
|||||
Standard potash – Southeast Asia |
CFR spot ($ per tonne) |
292 |
|
318 |
(8.2 |
)% |
283 |
3.2 |
% |
|||||
Potash imports |
|
|
|
|
|
|
|
|||||||
To Brazil |
million tonnes |
2.9 |
|
3.4 |
(14.7 |
)% |
3.9 |
(25.6 |
)% |
|||||
To China |
million tonnes |
3.4 |
|
3.6 |
(5.6 |
)% |
2.8 |
21.4 |
% |
|||||
To India |
million tonnes |
1.2 |
|
0.8 |
50.0 |
% |
0.6 |
100.0 |
% |
|||||
Sources: CRU (Fertilizer Week Historical Price: December 2024), SIACESP (Brazil), United Port Services (Brazil), FAI (India), Chinese customs data, Global Trade Tracker (GTT). |
Potash – Production and Sales
Thousands of tonnes |
10-12/2024 |
10-12/2023 |
1-12/2024 |
1-12/2023 |
||||
Production |
1,178 |
|
1,139 |
|
4,502 |
|
4,420 |
|
Total sales (including internal sales) |
1,259 |
|
1,179 |
|
4,556 |
|
4,683 |
|
Closing inventory |
229 |
|
284 |
|
229 |
|
284 |
Fourth quarter 2024
Full year 2024
Results analysis for the period October – December 2024
|
Sales |
Expenses |
Operating income |
||||||
|
$ millions |
||||||||
Q4 2023 figures |
474 |
|
(352 |
) |
122 |
|
|||
Quantity |
38 |
|
(19 |
) |
19 |
|
|||
Price |
(90 |
) |
- |
|
(90 |
) |
|||
Exchange rates |
- |
|
1 |
|
1 |
|
|||
Raw materials |
- |
|
(1 |
) |
(1 |
) |
|||
Energy |
- |
|
(3 |
) |
(3 |
) |
|||
Transportation |
- |
|
10 |
|
10 |
|
|||
Operating and other expenses |
- |
|
11 |
|
11 |
|
|||
Q4 2024 figures |
422 |
|
(353 |
) |
69 |
|
Phosphate Solutions
The Phosphate Solutions segment operates ICL's phosphate value chain and uses phosphate rock and fertilizer-grade phosphoric acid to produce phosphate-based specialty products with higher added value, as well as to produce and sell phosphate-based fertilizers.
Results of operations and key indicators (1)
|
10-12/2024 (2) |
10-12/2023 |
1-12/2024 |
1-12/2023 |
||||
|
$ millions |
$ millions |
$ millions |
$ millions |
||||
Segment Sales |
507 |
515 |
2,215 |
2,350 |
||||
Sales to external customers |
475 |
474 |
2,049 |
2,141 |
||||
Sales to internal customers |
32 |
41 |
166 |
209 |
||||
Segment Operating Income |
81 |
85 |
358 |
350 |
||||
Depreciation and amortization |
51 |
54 |
191 |
207 |
||||
Segment EBITDA |
132 |
139 |
549 |
557 |
||||
Capital expenditures |
147 |
89 |
340 |
270 |
(1) |
In alignment with the Company's efficiency plan, which included a change of reporting responsibilities, as of January 2024, the results of a non-phosphate related business were allocated from the Phosphate Solutions segment to Other Activities. Comparative figures have been restated to reflect the organizational change in the reportable segments. |
(2) |
For Q4 2024, Phosphate Specialties accounted for $309 million of segment sales, $44 million of operating income, $13 million of D&A and $57 million of EBITDA, while Phosphate Commodities accounted for $198 million of segment sales, $37 million of operating income, $38 million of D&A and represented $75 million of EBITDA. |
Significant highlights for the fourth quarter
Additional segment information
Global phosphate commodities market - average prices:
Average prices |
$ per tonne |
10-12/2024 |
10-12/2023 |
VS Q4 2023 |
7-9/2024 |
VS Q3 2024 |
||||||||
DAP |
CFR India Bulk Spot |
637 |
594 |
7 |
% |
598 |
7 |
% |
||||||
TSP |
CFR Brazil Bulk Spot |
500 |
422 |
18 |
% |
513 |
(3 |
)% |
||||||
SSP |
CPT Brazil inland 18-20% P2O5 Bulk Spot |
270 |
278 |
(3 |
)% |
305 |
(11 |
)% |
||||||
Sulphur |
Bulk FOB Adnoc monthly Bulk contract |
139 |
102 |
36 |
% |
106 |
31 |
% |
||||||
Source: CRU (Fertilizer Week Historical Prices, December 2024). |
Results analysis for the period October – December 2024
|
Sales |
Expenses |
Operating income |
||||||
|
$ millions |
||||||||
Q4 2023 figures |
515 |
|
(430 |
) |
85 |
|
|||
Quantity |
15 |
|
(5 |
) |
10 |
|
|||
Price |
(24 |
) |
- |
|
(24 |
) |
|||
Exchange rates |
1 |
|
3 |
|
4 |
|
|||
Raw materials |
- |
|
17 |
|
17 |
|
|||
Energy |
- |
|
1 |
|
1 |
|
|||
Transportation |
- |
|
6 |
|
6 |
|
|||
Operating and other expenses |
- |
|
(18 |
) |
(18 |
) |
|||
Q4 2024 figures |
507 |
|
(426 |
) |
81 |
|
Growing Solutions
The Growing Solutions segment aims to achieve global leadership in plant nutrition by enhancing its position in its core markets of specialty agriculture, ornamental horticulture, turf and landscaping, fertilizers and FertilizerpluS, and by targeting high-growth markets such as Brazil, India, and China. The segment leverages its unique R&D capabilities, substantial agronomic experience, global footprint, backward integration to potash, phosphate and polysulphate and its chemistry know-how, as well as its ability to integrate and generate synergies from acquired businesses. The segment continuously works to expand its broad portfolio of specialty plant nutrition, plant stimulation and plant health solutions, which consists of enhanced efficiency and controlled release fertilizers (CRF), water-soluble fertilizers (WSF), liquid fertilizers and straights (MKP/MAP/PeKacid), FertilizerpluS, soil and foliar micronutrients, biostimulants, soil conditioners, seed treatment products and adjuvants.
Results of operations and key indicators
|
10-12/2024 |
10-12/2023 |
1-12/2024 |
1-12/2023 |
||||
|
$ millions |
$ millions |
$ millions |
millions |
||||
Segment Sales |
439 |
478 |
1,950 |
2,073 |
||||
Sales to external customers |
435 |
475 |
1,932 |
2,047 |
||||
Sales to internal customers |
4 |
3 |
18 |
26 |
||||
Segment Operating Income |
31 |
(5) |
128 |
51 |
||||
Depreciation and amortization |
20 |
20 |
74 |
68 |
||||
Segment EBITDA |
51 |
15 |
202 |
119 |
||||
Capital expenditures |
44 |
36 |
98 |
92 |
Significant highlights for the fourth quarter
Regional highlights:
Product highlights:
Results analysis for the period October – December 2024
|
Sales |
Expenses |
Operating income |
||||||
|
$ millions |
||||||||
Q4 2023 figures |
478 |
|
(483 |
) |
(5 |
) |
|||
Quantity |
(27 |
) |
20 |
|
(7 |
) |
|||
Price |
10 |
|
- |
|
10 |
|
|||
Exchange rates |
(22 |
) |
18 |
|
(4 |
) |
|||
Raw materials |
- |
|
32 |
|
32 |
|
|||
Operating and other expenses |
- |
|
5 |
|
5 |
|
|||
Q4 2024 figures |
439 |
|
(408 |
) |
31 |
|
Financing expenses, net
Net financing expenses in the fourth quarter of 2024 amounted to $33 million, the same as the corresponding quarter of last year.
Tax expenses
In the fourth quarter of 2024, the Company's reported tax expenses amounted to $33 million, compared to $33 million in the corresponding quarter of last year, reflecting an effective tax rate of 29% and 28%, respectively.
Liquidity and Capital Resources
As of December 31, 2024, the Company's cash, cash equivalents, short-term investments and deposits amounted to $442 million compared to $592 million as of December 31, 2023. In addition, the Company maintained about $1.2 billion of unused credit facilities, as of December 31, 2024.
Outstanding net debt
As of December 31, 2024, ICL's net financial liabilities amounted to $1,851 million, a decrease of $244 million compared to December 31, 2023.
Credit facilities
Sustainability-linked Revolving Credit Facility (RCF)
In April 2023, the Company entered into a Sustainability-Linked Revolving Credit Facility Agreement between its subsidiary ICL Finance B.V., as borrower, and a consortium of 12 international banks for $1,550 million.
In April 2024, all the banks agreed to extend the RCF agreement for an additional year which is now due to expire in April 2029. As of December 31, 2024, the Company had utilized about $520 million of its $1,550 million credit facility framework.
Securitization
The total amount of the Company's committed securitization facility framework is $300 million, with an additional $100 million uncommitted. As of December 31, 2024, ICL had utilized approximately $176 million of the facility's framework.
Ratings and financial covenants
Fitch Ratings
In June of 2024, Fitch Ratings reaffirmed the Company's long-term issuer default rating and senior unsecured rating at 'BBB-'. The outlook on the long-term issuer default rating is stable.
S&P Ratings
In July of 2024, S&P reaffirmed the Company's international credit rating and senior unsecured rating of 'BBB-'. In addition, S&P Maalot reaffirmed the Company's credit rating of 'ilAA' with a stable rating outlook.
Financial covenants
As of December 31, 2024, the Company was in compliance with all of the financial covenants stipulated in its financing agreements.
Dividend Distribution
In connection with ICL's fourth quarter 2024 results, the Board of Directors declared a dividend of 4.03 cents per share, or approximately $52 million. The dividend will be paid on March 25, 2025. The record date is March 12, 2025.
About ICL
ICL Group Ltd. is a leading global specialty minerals company, which creates impactful solutions for humanity's sustainability challenges in the food, agriculture, and industrial markets. ICL leverages its unique bromine, potash, and phosphate resources, its global professional workforce, and its sustainability focused R&D and technological innovation capabilities, to drive the Company's growth across its end markets. ICL shares are dual listed on the New York Stock Exchange and the Tel Aviv Stock Exchange (NYSE and TASE: ICL). The Company employs more than 12,000 people worldwide, and its 2024 revenue totaled approximately $7 billion. For more information, visit the Company's website at www.icl-group.com1.
We disclose in this quarterly report non-IFRS financial measures titled adjusted operating income, adjusted net income attributable to the Company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA. Our management uses adjusted operating income, adjusted net income attributable to the Company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA to facilitate operating performance comparisons from period to period. We calculate our adjusted operating income by adjusting our operating income to add certain items, as set forth in the reconciliation table under "Adjustments to reported operating, and net income (non-GAAP)" below. Certain of these items may recur. We calculate our adjusted net income attributable to the Company's shareholders by adjusting our net income attributable to the Company's shareholders to add certain items, as set forth in the reconciliation table under "Adjustments to reported operating, and net income (non-GAAP)" below, excluding the total tax impact of such adjustments. We calculate our diluted adjusted earnings per share by dividing adjusted net income by the weighted-average number of diluted ordinary shares outstanding. Our adjusted EBITDA is calculated as net income before financing expenses, net, taxes on income, share in earnings of equity-accounted investees, depreciation and amortization, and certain adjustments presented in the reconciliation table under "Consolidated adjusted EBITDA, and diluted adjusted Earnings Per Share for the periods of activity" below, which were adjusted for in calculating the adjusted operating income.
You should not view adjusted operating income, adjusted net income attributable to the Company's shareholders, diluted adjusted earnings per share or adjusted EBITDA as a substitute for operating income or net income attributable to the Company's shareholders determined in accordance with IFRS, and you should note that our definitions of adjusted operating income, adjusted net income attributable to the Company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA may differ from those used by other companies. Additionally, other companies may use other measures to evaluate their performance, which may reduce the usefulness of our non-IFRS financial measures as tools for comparison. However, we believe adjusted operating income, adjusted net income attributable to the Company's shareholders, diluted adjusted earnings per share, and adjusted EBITDA provide useful information to both management, and investors by excluding certain items that management believes are not indicative of our ongoing operations. Our management uses these non-IFRS measures to evaluate the Company's business strategies and management performance. We believe that these non IFRS measures provide useful information to investors because they improve the comparability of our financial results between periods and provide for greater transparency of key measures used to evaluate our performance.
(1a) The Company only provides guidance on a non-GAAP basis. The Company does not provide a reconciliation of forward-looking adjusted EBITDA (non-GAAP) to GAAP net income (loss), due to the inherent difficulty in forecasting, and quantifying certain amounts that are necessary for such reconciliation, in particular, because special items such as restructuring, litigation, and other matters, used to calculate projected net income (loss) vary dramatically based on actual events, the Company is not able to forecast on a GAAP basis with reasonable certainty all deductions needed in order to provide a GAAP calculation of projected net income (loss) at this time. The amount of these deductions may be material, and therefore could result in projected GAAP net income (loss) being materially less than projected adjusted EBITDA (non-GAAP). The guidance speaks only as of the date hereof. We undertake no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law. The Company provides guidance for Specialties-driven EBITDA, which includes Industrial Products, Growing Solutions and Phosphate Solutions, as the Phosphate Solutions business is now predominantly specialties-focused. For our Potash business we provide sales volumes guidance. The Company believes this information provides greater transparency, as these new metrics are less impacted by fertilizer commodity prices, given the extreme volatility in recent years.
We present a discussion in the period-to-period comparisons of the primary drivers of change in the Company's results of operations. This discussion is based in part on management's best estimates of the impact of the main trends on our businesses. We have based the following discussion on our financial statements. You should read such discussion together with our financial statements.
_________________
1 The reference to our website is intended to be an inactive textual reference and the information on, or accessible through, our website is not intended to be part of this Form 6-K.
Adjustments to Reported Operating and Net income (non-GAAP)
|
10-12/2024 |
10-12/2023 |
1-12/2024 |
1-12/2023 |
||||||||
|
$ millions |
$ millions |
$ millions |
$ millions |
||||||||
Operating income |
147 |
|
149 |
|
775 |
|
1,141 |
|
||||
Charges related to the security situation in Israel (1) |
17 |
|
14 |
|
57 |
|
14 |
|
||||
Impairment and write-off of assets and provision for site closure (2) |
20 |
|
34 |
|
35 |
|
49 |
|
||||
Provision for early retirement (3) |
4 |
|
16 |
|
4 |
|
16 |
|
||||
Legal proceedings (4) |
2 |
|
(2 |
) |
2 |
|
(2 |
) |
||||
Total adjustments to operating income |
43 |
|
62 |
|
98 |
|
77 |
|
||||
Adjusted operating income |
190 |
|
211 |
|
873 |
|
1,218 |
|
||||
Net income attributable to the shareholders of the Company |
70 |
|
67 |
|
407 |
|
647 |
|
||||
Total adjustments to operating income |
43 |
|
62 |
|
98 |
|
77 |
|
||||
Total tax adjustments (5) |
(9 |
) |
(6 |
) |
(21 |
) |
(9 |
) |
||||
Total adjusted net income - shareholders of the Company |
104 |
|
123 |
|
484 |
|
715 |
|
(1) |
For 2024 and 2023, reflects charges relating to the security situation in Israel. |
(2) |
For 2024, reflects mainly a write-off of assets resulting from the closure of small sites in Israel and Turkey, and an impairment of assets due to a regulatory decision that mandated the cessation of a certain project. For 2023, reflects mainly a write-off of assets related to restructuring at certain sites, including site closures and facility modifications, as part of the Company's global efficiency plan. |
(3) |
For 2024 and 2023, reflects provisions for early retirement, due to restructuring at certain sites, as part of the Company's global efficiency plan. |
(4) |
For 2024, reflects reimbursement of arbitration costs associated with the Ethiopian potash project. For 2023, reflects a reversal of a legal provision. |
(5) |
For 2024 and 2023, reflects the tax impact of adjustments made to operating income. |
Consolidated adjusted EBITDA and diluted adjusted Earnings Per Share for the periods of activity
Calculation of adjusted EBITDA was made as follows:
|
10-12/2024 |
10-12/2023 |
1-12/2024 |
1-12/2023 |
|||||||
|
$ millions |
$ millions |
$ millions |
$ millions |
|||||||
Net income |
81 |
84 |
|
464 |
|
687 |
|
||||
Financing expenses, net |
33 |
33 |
|
140 |
|
168 |
|
||||
Taxes on income |
33 |
33 |
|
172 |
|
287 |
|
||||
Less: Share in earnings of equity-accounted investees |
- |
(1 |
) |
(1 |
) |
(1 |
) |
||||
Operating income |
147 |
149 |
|
775 |
|
1,141 |
|
||||
Depreciation and amortization |
157 |
146 |
|
596 |
|
536 |
|
||||
Adjustments (1) |
43 |
62 |
|
98 |
|
77 |
|
||||
Total adjusted EBITDA (2) |
347 |
357 |
|
1,469 |
|
1,754 |
|
(1) |
See "Adjustments to Reported Operating and Net income (non-GAAP)" above. |
(2) |
In 2024, the Company's adjusted EBITDA was positively impacted by an immaterial accounting reclassification. For further information, see our Potash segment results above. |
Calculation of diluted adjusted earnings per share was made as follows:
|
10-12/2024 |
10-12/2023 |
1-12/2024 |
1-12/2023 |
||||||||
|
$ millions |
$ millions |
$ millions |
$ millions |
||||||||
Net income attributable to the Company's shareholders |
70 |
|
67 |
|
407 |
|
647 |
|
||||
Adjustments (1) |
43 |
|
62 |
|
98 |
|
77 |
|
||||
Total tax adjustments |
(9 |
) |
(6 |
) |
(21 |
) |
(9 |
) |
||||
Adjusted net income - shareholders of the Company |
104 |
|
123 |
|
484 |
|
715 |
|
||||
Weighted-average number of diluted ordinary shares outstanding (in thousands) |
1,290,330 |
|
1,290,575 |
|
1,290,039 |
|
1,290,668 |
|
||||
Diluted adjusted earnings per share (in dollars) (2) |
0.08 |
|
0.10 |
|
0.38 |
|
0.55 |
|
(1) |
See "Adjustments to Reported Operating and Net income (non-GAAP)" above. |
(2) |
The diluted adjusted earnings per share is calculated by dividing the adjusted net income shareholders of the Company by the weighted-average number of diluted ordinary shares outstanding (in thousands). |
Consolidated Results Analysis
Results analysis for the period October – December 2024
|
Sales |
Expenses |
Operating income |
||||||
|
$ millions |
||||||||
Q4 2023 figures |
1,690 |
|
(1,541 |
) |
149 |
|
|||
Total adjustments Q4 2023 |
- |
|
62 |
|
62 |
|
|||
Adjusted Q4 2023 figures |
1,690 |
|
(1,479 |
) |
211 |
|
|||
Quantity |
26 |
|
(7 |
) |
19 |
|
|||
Price |
(92 |
) |
- |
|
(92 |
) |
|||
Exchange rates |
(23 |
) |
22 |
|
(1 |
) |
|||
Raw materials |
- |
|
51 |
|
51 |
|
|||
Energy |
- |
|
(1 |
) |
(1 |
) |
|||
Transportation |
- |
|
11 |
|
11 |
|
|||
Operating and other expenses |
- |
|
(8 |
) |
(8 |
) |
|||
Adjusted Q4 2024 figures |
1,601 |
|
(1,411 |
) |
190 |
|
|||
Total adjustments Q4 2024* |
- |
|
(43 |
) |
(43 |
) |
|||
Q4 2024 figures |
1,601 |
|
(1,454 |
) |
147 |
|
|||
* See "Adjustments to reported Operating and Net income (non-GAAP)" above. |
Security situation in Israel
In October 2023, the Israeli government declared a state of war in response to attacks on its civilians in the south of the country, which escalated to other areas. The security situation has presented several challenges, including disruptions in supply chains and shipping routes, personnel shortages due to recurring rounds of mobilization for reserve duty, additional costs to protect Company sites/assets, effects of reluctance to perform contractual obligations in Israel during hostilities, various bans and limitations on trade and cooperation with Israel related entities, and fluctuations in foreign currency exchange rates relative to the Israeli shekel. Additionally, regional tensions involving Houthis attacks and threats to commercial vessels have intensified, disrupting shipping routes and commercial shipping arrangements, leading to increased shipping costs.
The Company continues to take measures to ensure the safety of its employees and business partners, as well as the communities in which it operates. It has also implemented supportive measures to accommodate employees called for reserve duty, aiming to minimize any potential impact on its business, and to avoid disruptions to production activities at its facilities in Israel.
The security situation in the last year has not had a material impact on the Company's business results. However, as the developments related to the war, as well as its duration, are unpredictable, the Company is unable to estimate the extent of the war's potential impact on its future business and results. The Company continuously monitors developments and will take all necessary actions to minimize any negative consequences to its operations and assets.
Forward-looking Statements
This announcement contains statements that constitute "forward-looking statements", many of which can be identified by the use of forward-looking words such as "anticipate", "believe", "could", "expect", "should", "plan", "intend", "estimate", "strive", "forecast", "targets" and "potential", among others.
Forward-looking statements appear in a number of places in this announcement and include, but are not limited to, statements regarding our intent, belief or current expectations. Forward-looking statements are based on our management's beliefs and assumptions and on information currently available to our management. Such statements are subject to risks and uncertainties, and the actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including, but not limited to:
Changes in exchange rates or prices compared to those we are currently experiencing; loss or impairment of business licenses or mineral extractions permits or concessions; volatility of supply and demand and the impact of competition; the difference between actual reserves and our reserve estimates; natural disasters and cost of compliance with environmental regulatory legislative and licensing restrictions including laws and regulation related to, and physical impacts of climate change and greenhouse gas emissions; failure to "harvest" salt which could lead to accumulation of salt at the bottom of the evaporation Pond 5 in the Dead Sea; disruptions at our seaport shipping facilities or regulatory restrictions affecting our ability to export our products overseas; general market, political or economic conditions in the countries in which we operate; price increases or shortages with respect to our principal raw materials; delays in termination of engagements with contractors and/or governmental obligations; the inflow of significant amounts of water into the Dead Sea which could adversely affect production at our plants; labor disputes, slowdowns and strikes involving our employees; pension and health insurance liabilities; Pandemics may create disruptions, impacting our sales, operations, supply chain and customers; changes to governmental incentive programs or tax benefits, creation of new fiscal or tax related legislation; and/or higher tax liabilities; changes in our evaluations and estimates, which serve as a basis for the recognition and manner of measurement of assets and liabilities; failure to integrate or realize expected benefits from mergers and acquisitions, organizational restructuring and joint ventures; currency rate fluctuations; rising interest rates; government examinations or investigations; disruption of our, or our service providers', information technology systems or breaches of our, or our service providers', data security; failure to retain and/or recruit key personnel; inability to realize expected benefits from our cost reduction program according to the expected timetable; inability to access capital markets on favorable terms; cyclicality of our businesses; changes in demand for our fertilizer products due to a decline in agricultural product prices, lack of available credit, weather conditions, government policies or other factors beyond our control; sales of our magnesium products being affected by various factors that are not within our control; our ability to secure approvals and permits from the authorities in Israel to continue our phosphate mining operations in Rotem Amfert Israel; volatility or crises in the financial markets; hazards inherent to mining and chemical manufacturing; the failure to ensure the safety of our workers and processes; litigation, arbitration and regulatory proceedings; exposure to third party and product liability claims; product recalls or other liability claims as a result of food safety and food-borne illness concerns; insufficiency of insurance coverage; closing of transactions, mergers and acquisitions; war or acts of terror and/or political, economic and military instability in Israel and its region; including the current state of war declared in Israel and any resulting disruptions to our supply and production chains; filing of class actions and derivative actions against the Company, its executives and Board members; The Company is exposed to risks relating to its current and future activity in emerging markets; and other risk factors discussed under "Item 3 - Key Information— D. Risk Factors" in the Company's Annual Report on Form 20-F for the year ended December 31, 2023, filed with the U.S. Securities and Exchange Commission (the "SEC") on March 14, 2023 (the "Annual Report").
Forward looking statements speak only as at the date they are made, and we do not undertake any obligation to update them in light of new information or future developments or to release publicly any revisions to these statements in order to reflect later events or circumstances or to reflect the occurrence of unanticipated events.
This report for the fourth quarter of 2024 (the "Quarterly Report") should be read in conjunction with the Annual Report and the report for the first, second and third quarters of 2024 published by the Company (the "prior quarterly reports"), including the description of the events occurring subsequent to the date of the statement of financial position, as filed with the U.S. SEC.
Appendix:
Condensed Consolidated Statements of Financial Position as of (Unaudited) |
||||
|
December 31, 2024 |
December 31, 2023 |
||
|
$ millions |
$ millions |
||
Current assets |
|
|
||
Cash and cash equivalents |
327 |
420 |
||
Short-term investments and deposits |
115 |
172 |
||
Trade receivables |
1,260 |
1,376 |
||
Inventories |
1,626 |
1,703 |
||
Prepaid expenses and other receivables |
258 |
363 |
||
Total current assets |
3,586 |
4,034 |
||
|
|
|
||
Non-current assets |
|
|
||
Deferred tax assets |
143 |
152 |
||
Property, plant and equipment |
6,462 |
6,329 |
||
Intangible assets |
869 |
873 |
||
Other non-current assets |
261 |
239 |
||
Total non-current assets |
7,735 |
7,593 |
||
|
|
|
||
Total assets |
11,321 |
11,627 |
||
|
|
|
||
Current liabilities |
|
|
||
Short-term debt |
384 |
858 |
||
Trade payables |
1,002 |
912 |
||
Provisions |
63 |
85 |
||
Other payables |
879 |
783 |
||
Total current liabilities |
2,328 |
2,638 |
||
|
|
|
||
Non-current liabilities |
|
|
||
Long-term debt and debentures |
1,909 |
1,829 |
||
Deferred tax liabilities |
481 |
489 |
||
Long-term employee liabilities |
331 |
354 |
||
Long-term provisions and accruals |
230 |
224 |
||
Other |
55 |
56 |
||
Total non-current liabilities |
3,006 |
2,952 |
||
|
|
|
||
Total liabilities |
5,334 |
5,590 |
||
|
|
|
||
Equity |
|
|
||
Total shareholders' equity |
5,724 |
5,768 |
||
Non-controlling interests |
263 |
269 |
||
Total equity |
5,987 |
6,037 |
||
|
|
|
||
Total liabilities and equity |
11,321 |
11,627 |
Condensed Consolidated Statements of Income (Unaudited) (In millions except per share data) |
||||||||||||
|
For the three-month period ended December 31 |
|
For the year ended December 31 |
|||||||||
|
2024 |
|
2023 |
|
2024 |
|
2023 |
|||||
|
$ millions |
|
$ millions |
|
$ millions |
|
$ millions |
|||||
Sales |
1,601 |
|
1,690 |
|
6,841 |
|
7,536 |
|
||||
Cost of sales |
1,066 |
|
1,130 |
|
4,585 |
|
4,865 |
|
||||
|
|
|
|
|
||||||||
Gross profit |
535 |
|
560 |
|
2,256 |
|
2,671 |
|
||||
|
|
|
|
|
||||||||
Selling, transport and marketing expenses |
281 |
|
286 |
|
1,114 |
|
1,093 |
|
||||
General and administrative expenses |
68 |
|
71 |
|
259 |
|
260 |
|
||||
Research and development expenses |
19 |
|
17 |
|
69 |
|
71 |
|
||||
Other expenses |
33 |
|
44 |
|
60 |
|
128 |
|
||||
Other income |
(13 |
) |
(7 |
) |
(21 |
) |
(22 |
) |
||||
|
|
|
|
|
||||||||
Operating income |
147 |
|
149 |
|
775 |
|
1,141 |
|
||||
|
|
|
|
|
||||||||
Finance expenses |
71 |
|
38 |
|
181 |
|
259 |
|
||||
Finance income |
(38 |
) |
(5 |
) |
(41 |
) |
(91 |
) |
||||
Finance expenses, net |
33 |
|
33 |
|
140 |
|
168 |
|
||||
|
|
|
|
|
||||||||
Share in earnings of equity-accounted investees |
- |
|
1 |
|
1 |
|
1 |
|
||||
|
|
|
|
|
||||||||
Income before taxes on income |
114 |
|
117 |
|
636 |
|
974 |
|
||||
|
|
|
|
|
||||||||
Taxes on income |
33 |
|
33 |
|
172 |
|
287 |
|
||||
|
|
|
|
|
||||||||
Net income |
81 |
|
84 |
|
464 |
|
687 |
|
||||
|
|
|
|
|
||||||||
Net income attributable to the non-controlling interests |
11 |
|
17 |
|
57 |
|
40 |
|
||||
|
|
|
|
|
||||||||
Net income attributable to the shareholders of the Company |
70 |
|
67 |
|
407 |
|
647 |
|
||||
|
|
|
|
|
||||||||
Earnings per share attributable to the shareholders of the Company: |
|
|
|
|
||||||||
|
|
|
|
|
||||||||
Basic earnings per share (in dollars) |
0.06 |
|
0.05 |
|
0.32 |
|
0.50 |
|
||||
|
|
|
|
|
||||||||
Diluted earnings per share (in dollars) |
0.06 |
|
0.05 |
|
0.32 |
|
0.50 |
|
||||
|
|
|
|
|
||||||||
Weighted-average number of ordinary shares outstanding: |
|
|
|
|
||||||||
|
|
|
|
|
||||||||
Basic (in thousands) |
1,290,260 |
|
1,289,449 |
|
1,289,968 |
|
1,289,361 |
|
||||
|
|
|
|
|
||||||||
Diluted (in thousands) |
1,290,330 |
|
1,290,575 |
|
1,290,039 |
|
1,290,668 |
|
The accompanying notes are an integral part of these condensed consolidated interim financial statements.
Condensed Consolidated Statements of Cash Flows (Unaudited) |
||||||||||||
|
For the three-month period ended |
For the year ended |
||||||||||
|
December 31, 2024 |
December 31, 2023 |
December 31, 2024 |
December 31, 2023 |
||||||||
|
$ millions |
$ millions |
$ millions |
$ millions |
||||||||
Cash flows from operating activities |
|
|
|
|
||||||||
Net income |
81 |
|
84 |
|
464 |
|
687 |
|
||||
Adjustments for: |
|
|
|
|
||||||||
Depreciation and amortization |
157 |
|
146 |
|
596 |
|
536 |
|
||||
Fixed assets impairment |
7 |
|
- |
|
14 |
|
- |
|
||||
Exchange rate, interest and derivative, net |
47 |
|
(51 |
) |
152 |
|
24 |
|
||||
Tax expenses |
33 |
|
33 |
|
172 |
|
287 |
|
||||
Change in provisions |
3 |
|
9 |
|
(50 |
) |
(32 |
) |
||||
Other |
7 |
|
22 |
|
13 |
|
29 |
|
||||
|
254 |
|
159 |
|
897 |
|
844 |
|
||||
|
|
|
|
|
||||||||
Change in inventories |
(102 |
) |
50 |
|
(7 |
) |
465 |
|
||||
Change in trade receivables |
68 |
|
47 |
|
26 |
|
252 |
|
||||
Change in trade payables |
87 |
|
66 |
|
104 |
|
(101 |
) |
||||
Change in other receivables |
66 |
|
37 |
|
39 |
|
26 |
|
||||
Change in other payables |
39 |
|
16 |
|
43 |
|
(210 |
) |
||||
Net change in operating assets and liabilities |
158 |
|
216 |
|
205 |
|
432 |
|
||||
|
|
|
|
|
||||||||
Income taxes paid, net of refund |
(41 |
) |
(7 |
) |
(98 |
) |
(253 |
) |
||||
|
|
|
|
|
||||||||
Net cash provided by operating activities (*) |
452 |
|
452 |
|
1,468 |
|
1,710 |
|
||||
|
|
|
|
|
||||||||
Cash flows from investing activities |
|
|
|
|
||||||||
Proceeds (payments) from deposits, net |
(5 |
) |
(10 |
) |
56 |
|
(88 |
) |
||||
Purchases of property, plant and equipment and intangible assets |
(267 |
) |
(255 |
) |
(713 |
) |
(780 |
) |
||||
Proceeds from divestiture of assets and businesses, net of transaction expenses |
- |
|
- |
|
19 |
|
4 |
|
||||
Interest received (*) |
3 |
|
3 |
|
17 |
|
10 |
|
||||
Business combinations |
(2 |
) |
- |
|
(74 |
) |
- |
|
||||
Other |
1 |
|
- |
|
1 |
|
1 |
|
||||
Net cash used in investing activities |
(270 |
) |
(262 |
) |
(694 |
) |
(853 |
) |
||||
|
|
|
|
|
||||||||
Cash flows from financing activities |
|
|
|
|
||||||||
Dividends paid to the Company's shareholders |
(68 |
) |
(68 |
) |
(251 |
) |
(474 |
) |
||||
Receipts of long-term debt |
278 |
|
149 |
|
889 |
|
633 |
|
||||
Repayments of long-term debt |
(383 |
) |
(183 |
) |
(1,302 |
) |
(836 |
) |
||||
Receipts (Repayments) of short-term debt |
(8 |
) |
64 |
|
(1 |
) |
(25 |
) |
||||
Interest paid (*) |
(43 |
) |
(40 |
) |
(122 |
) |
(125 |
) |
||||
Receipts (payments) from transactions in derivatives |
(3 |
) |
(1 |
) |
(2 |
) |
5 |
|
||||
Dividend paid to the non-controlling interests |
- |
|
- |
|
(57 |
) |
(15 |
) |
||||
Net cash used in financing activities |
(227 |
) |
(79 |
) |
(846 |
) |
(837 |
) |
||||
|
|
|
|
|
||||||||
Net change in cash and cash equivalents |
(45 |
) |
111 |
|
(72 |
) |
20 |
|
||||
Cash and cash equivalents as of the beginning of the period |
393 |
|
307 |
|
420 |
|
417 |
|
||||
Net effect of currency translation on cash and cash equivalents |
(21 |
) |
2 |
|
(21 |
) |
(17 |
) |
||||
Cash and cash equivalents as of the end of the period |
327 |
|
420 |
|
327 |
|
420 |
|
||||
(*) Reclassification - of interest received as cash flows from investing activities and interest paid as cash flows from financing activities, instead of under cash provided by operating activities. |
Operating segment data |
|||||||||||||||||
|
Industrial Products |
Potash |
Phosphate Solutions |
Growing Solutions |
Other Activities |
Reconciliations |
Consolidated |
||||||||||
|
$ millions |
||||||||||||||||
For the three-month period ended December 31, 2024 |
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
||||||||||
Sales to external parties |
275 |
373 |
475 |
435 |
43 |
|
- |
|
1,601 |
|
|||||||
Inter-segment sales |
5 |
49 |
32 |
4 |
- |
|
(90 |
) |
- |
|
|||||||
Total sales |
280 |
422 |
507 |
439 |
43 |
|
(90 |
) |
1,601 |
|
|||||||
|
|
|
|
|
|
|
|
||||||||||
Cost of sales |
177 |
260 |
344 |
313 |
44 |
|
(72 |
) |
1,066 |
|
|||||||
Segment operating income (loss) |
55 |
69 |
81 |
31 |
(8 |
) |
(38 |
) |
190 |
|
|||||||
Other expenses not allocated to the segments |
|
|
|
|
|
|
(43 |
) |
|||||||||
Operating income |
|
|
|
|
|
|
147 |
|
|||||||||
|
|
|
|
|
|
|
|
||||||||||
Financing expenses, net |
|
|
|
|
|
|
(33 |
) |
|||||||||
|
|
|
|
|
|
|
|
||||||||||
Income before income taxes |
|
|
|
|
|
|
114 |
|
|||||||||
|
|
|
|
|
|
|
|
||||||||||
Depreciation, amortization and impairment |
15 |
61 |
51 |
20 |
4 |
|
13 |
|
164 |
|
|||||||
Capital expenditures |
38 |
116 |
147 |
44 |
3 |
|
12 |
|
360 |
|
|||||||
Capital expenditures as part of business combination |
- |
- |
- |
4 |
- |
|
- |
|
4 |
|
|||||||
Operating segment data (cont'd) |
||||||||||||||||||
|
Industrial Products |
Potash |
Phosphate Solutions |
Growing Solutions |
Other Activities |
Reconciliations |
Consolidated |
|||||||||||
|
$ millions |
|||||||||||||||||
For the three-month period ended December 31, 2023 |
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Sales to external parties |
294 |
408 |
474 |
475 |
|
39 |
|
- |
|
1,690 |
|
|||||||
Inter-segment sales |
5 |
66 |
41 |
3 |
|
(1 |
) |
(114 |
) |
- |
|
|||||||
Total sales |
299 |
474 |
515 |
478 |
|
38 |
|
(114 |
) |
1,690 |
|
|||||||
|
|
|
|
|
|
|
|
|||||||||||
Cost of sales |
217 |
243 |
348 |
375 |
|
45 |
|
(98 |
) |
1,130 |
|
|||||||
Segment operating income (loss) |
39 |
122 |
85 |
(5 |
) |
(12 |
) |
(18 |
) |
211 |
|
|||||||
Other expenses not allocated to the segments |
|
|
|
|
|
|
(62 |
) |
||||||||||
Operating income |
|
|
|
|
|
|
149 |
|
||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Financing expenses, net |
|
|
|
|
|
|
(33 |
) |
||||||||||
Share in earnings of equity-accounted investees |
|
|
|
|
|
|
1 |
|
||||||||||
Income before income taxes |
|
|
|
|
|
|
117 |
|
||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Depreciation and amortization |
17 |
46 |
54 |
20 |
|
6 |
|
3 |
|
146 |
|
|||||||
|
|
|
|
|
|
|
|
|||||||||||
Capital expenditures |
29 |
132 |
89 |
36 |
|
6 |
|
12 |
|
304 |
|
Information based on geographical location
The following table presents the distribution of the operating segments sales by geographical location of the customer:
|
10-12/2024 |
10-12/2023 |
||||||
|
$ millions |
% of sales |
$ millions |
% of sales |
||||
USA |
280 |
17 |
295 |
17 |
||||
Brazil |
276 |
17 |
347 |
21 |
||||
China |
274 |
17 |
284 |
17 |
||||
Spain |
73 |
5 |
77 |
5 |
||||
Israel |
69 |
4 |
72 |
4 |
||||
Germany |
65 |
4 |
68 |
4 |
||||
India |
64 |
4 |
29 |
2 |
||||
United Kingdom |
58 |
4 |
74 |
4 |
||||
France |
48 |
3 |
63 |
4 |
||||
Netherlands |
37 |
2 |
27 |
2 |
||||
All other |
357 |
23 |
354 |
20 |
||||
Total |
1,601 |
100 |
1,690 |
100 |
View source version on businesswire.com: https://www.businesswire.com/news/home/20250224694694/en/
Investor and Press Contact – Global Peggy Reilly Tharp VP, Global Investor Relations +1-314-983-7665 Peggy.ReillyTharp@icl-group.com
Investor and Press Contact - Israel Adi Bajayo ICL Spokesperson +972-3-6844459 Adi.Bajayo@icl-group.com